Danaher teams up with Microsoft to boost ‘experimental execution’
Danaher Corporation and Microsoft are teaming for a strategic partnership to develop smart scientific instruments and an interoperable agentic ecosystem.
MedTech Danaher teams up with Microsoft to boost ‘experimental execution’ By Patrick McGuire Nov 22, 2026 2:44am Microsoft Danaher Corp Artificial Intelligence Diagnostics Danaher Corporation and Microsoft are teaming for a strategic partnership to develop smart scientific instruments and an interoperable agentic ecosystem. Danaher said the envisioned system will connect its technologies while remaining open to the broader laboratory ecosystem, helping scientists move from scientific questions to experimental evidence faster. Along with Ely Lilly and Thermo Fisher Scientific’s partnerships with Nvidia, both announced this year, Danaher’s team-up with Microsoft represents medtech’s growing intertwinement with the world’s largest tech companies.
The partnership pairs Danaher's scientific, workflow and instrumentation expertise with Microsoft's AI technologies, and will make experimental execution more streamlined and insights more readily available, according to Danaher. The platform will be built on Microsoft technology: Microsoft Azure for compliant cloud infrastructure, and Microsoft Foundry to power the AI agents that interpret results and guide instrument control. Its goal is to enable reuse and interoperability across technologies, allowing specialized products to be built on a shared foundation while remaining open to agents and digital solutions in multi-vendor laboratories.
While the companies are continuing to develop this platform, the first commercial applications will reach Danaher customers this year, including MetaXpress Acquire AI Assistant, Molecular Devices' software for its high-content cellular imaging systems, designed to provide product support. Additional next-generation, agent-enabled instruments from Danaher businesses that use this platform are planned for 2027, the company said. "With Microsoft we are building a common foundation, so our instruments and laboratories work together consistently, as one connected Danaher,” said Julie Sawyer Montgomery, president and CEO of Danaher, in a statement.
“Through context and learning, that foundation can continuously inform the next experiment and the best analysis. This partnership is an important step toward making laboratories not just connected, but intelligent." Smart, agent-enabled instruments are being designed through the partnership to translate scientific intent into experimental plans, instrument setups, and methods, control instrument hardware, interpret results and identify quality issues in real time, and recommend corrective actions and next experiments for scientist review. In preliminary internal testing data shared by Danaher, novice scientists conducting an AI-assisted experiment on a Leica microscope took up to 83% less time and up to 68% fewer steps to complete than a novice working without the AI assistant, while producing high-quality data and completing the experiment in a time comparable to an expert.
The partnership is designed to advance Danaher's broader strategy for AI and autonomous science by connecting intelligence at the instrument with data, laboratory workflows, and the physical execution of experiments. Intelligent instruments are a first step. Microsoft Danaher Corp Artificial Intelligence Diagnostics MedTech
comments(0)
5-min edit window · permanent after that